28 julio 2015
The participation rate of patients in pharmacogenomic trials has been the focus of recent study. The research has concluded that there are a number of factors at the patient, physician, institution and community level that serve as incentives or hindrances for clinical trial participation, including beliefs and attitudes, awareness, opportunities and resources.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/ffdgEH3FJlM» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ffdgEH3FJlM/150728110529.htm
